Jump to content

Xalt2 study (NSCLC/ALK+)


Recommended Posts



If you have non-small cell lung cancer (NSCLC) that is ALK positive, you may be interested in learning more about a clinical research study opportunity.


The Xalt2 study is being done to find out if an investigational medication is safe and how tumors respond to it in patients with NSCLC whose tumors test positive for the ALK gene.


You may be able to join the Xalt2 clinical research study if you:


·         Are 18 years of age or older

·         Have been diagnosed with ALK positive NSCLC

Study participants will receive the investigational medication in cycles of approximately 28 days each. Not all participants will be in the study for the same amount of time.


To learn more: www.MyXalt2Study.com


Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.